PedAM

Pediatric Disease Annotations & Medicines

Disease	lung disease
Phenotype	\|cystic fibrosis
Sentences	64
PubMedID- 22431492	Background: hypoxemia during sleep is a common finding in cystic fibrosis (cf) patients with more advanced lung disease.
PubMedID- 23272037	It is known that low doses of dexamethasone slow the progression of lung disease in patients with cystic fibrosis through its role in reducing the inflammation associated with the bacterial infection [26].
PubMedID- 23748649	Correlation between computed tomography expression of pulmonary hypertension and severity of lung disease in cystic fibrosis patients.
PubMedID- 25222938	Pulmonary hypertension in cystic fibrosis with advanced lung disease.
PubMedID- 25216826	Mycobacterium abscessus complex is a group of rapidly growing mycobacteria, and an emerging cause of non-tuberculous mycobacterial lung disease in patients with cystic fibrosis and chronic lung diseases, such as bronchiectasis.
PubMedID- 22497648	We report a 29 year old male cystic fibrosis patient with end stage lung disease and normal renal function who underwent a sequential double lung transplant.
PubMedID- 24261460	Rationale: previous studies of risk factors for progression of lung disease in cystic fibrosis (cf) have suffered from limitations that preclude a comprehensive understanding of the determinants of cf lung disease throughout childhood.
PubMedID- 21942462	Objective: guidelines recommend chronic use of tobramycin solution for inhalation (tsi) for cystic fibrosis (cf) patients with moderate-to-severe lung disease and persistent airway pseudomonas aeruginosa.
PubMedID- 25629612	Changes in the airway microbiome may be important in the pathophysiology of chronic lung disease in patients with cystic fibrosis.
PubMedID- 21154377	Antioxidant micronutrients for lung disease in cystic fibrosis.
PubMedID- 26403534	lung disease in cystic fibrosis is characterized by neutrophilic inflammation, retention of mucoid secretions and chronic endobronchial infection with specific organisms, most notably pseudomonas aeruginosa.
PubMedID- 20693248	Outcome measures to assess therapeutic interventions in cystic fibrosis (cf) patients with mild lung disease are lacking.
PubMedID- 25963404	Background: cystic fibrosis (cf) leads to advanced lung disease despite aggressive care.
PubMedID- 22645424	The pathogenesis of lung disease in cystic fibrosis is characterised by decreased airway surface liquid volume and subsequent failure of normal mucociliary clearance.

Page: 1 2